Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers Read more
Neurogene Announces EMA Grants Orphan Drug Designation for Aspartylglucosaminuria Gene Therapy Read more
First Patient Dosed in Appili Therapeutics’ Phase 3 Clinical Trial of Avigan Tablets (Favipiravir) for the Treatment of COVID-19 in the United States Read more
Merck and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology Read more
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies Read more
Exelixis In-Licenses Iconic Therapeutics’ Tissue Factor-Targeting Antibody-Drug Conjugate Ahead of Planned Investigational New Drug Application Read more
Lilly announces 650,000 additional doses of neutralizing antibody bamlanivimab (LY-CoV555) purchased by U.S. government to treat COVID-19 Read more
Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-Stage Age-Related Macular Degeneration Read more
Boston Scientific Receives FDA Approval for WaveWriter Alpha Spinal Cord Stimulator Systems Read more
Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in HER2-Amplified Biliary Tract Cancer in Asia in Collaboration With BeiGene Read more